Hemorrhagic conversion after alteplase administration in a patient with vasculitis and acute ischemic stroke

Am J Health Syst Pharm. 2019 Feb 1;76(4):211-213. doi: 10.1093/ajhp/zxy048.

Abstract

Purpose: A case of alteplase administration to a patient with vasculitis and acute ischemic stroke (AIS) is reported.

Summary: A 38-year-old woman with a recent diagnosis of granulomatosis with polyangiitis (GPA) received alteplase for AIS and developed symptomatic hemorrhagic conversion. Published reports regarding the safety of thrombolytic therapy in patients with a high inflammatory burden are inconsistent. The current case adds to the literature on the topic.

Conclusion: More data regarding alteplase treatment in patients with GPA are needed to further establish the safety of this therapy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Brain Ischemia / complications
  • Brain Ischemia / diagnostic imaging
  • Brain Ischemia / drug therapy*
  • Cerebral Hemorrhage / chemically induced*
  • Cerebral Hemorrhage / complications
  • Cerebral Hemorrhage / diagnostic imaging
  • Female
  • Fibrinolytic Agents / adverse effects*
  • Humans
  • Stroke / complications
  • Stroke / diagnostic imaging
  • Stroke / drug therapy*
  • Tissue Plasminogen Activator / adverse effects*
  • Vasculitis / complications
  • Vasculitis / diagnostic imaging
  • Vasculitis / drug therapy*

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator